Intramitochondrial Src kinase links mitochondrial dysfunctions and aggressiveness of breast cancer cells

Marie-Ange Djeungoue-Petga1,2, Olivier Lurette1,2, Stéphanie Jean1,2

  • 1Canada Research Chair in Mitochondrial Signaling and Physiopathology, Moncton, NB, Canada.

Cell Death & Disease
|December 11, 2019
PubMed

Insights

Mitochondrial Src (mtSrc) kinase activity is elevated in triple-negative breast cancer, driving cancer aggressiveness by impairing mitochondrial function and DNA replication. Targeting mtSrc may offer novel therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Mitochondrial Biology

Background:

  • Src kinase is frequently overexpressed in breast cancer, and its inhibition is a therapeutic target.
  • Mitochondrial dysfunction is implicated in various cancer types.
  • The specific role of mitochondrial Src (mtSrc) in breast cancer remains largely unexplored.

Purpose of the Study:

  • To investigate the specific impact of mtSrc on breast cancer cell behavior.
  • To determine if mtSrc activity differs across breast cancer subtypes.
  • To elucidate the molecular mechanisms by which mtSrc influences mitochondrial function and cancer progression.

Main Methods:

  • Comparative analysis of mtSrc activity in different breast cancer subtypes.
  • Experimental manipulation of mtSrc expression in breast cancer cells.
  • Assessment of mitochondrial parameters including mtDNA levels, membrane potential, and respiration.
  • Proteomic analysis to identify mtSrc targets within mitochondria.

Main Results:

  • mtSrc activity was significantly higher in triple-negative breast cancer cells.
  • Overexpression of mtSrc led to decreased mtDNA levels, reduced mitochondrial membrane potential, and impaired cellular respiration.
  • These mitochondrial alterations correlated with decreased cellular viability, a shorter cell cycle, and increased invasive capacity.
  • Proteomic analysis identified the mitochondrial single-stranded DNA-binding protein as a key target of mtSrc.

Conclusions:

  • mtSrc plays a critical role in promoting breast cancer aggressiveness, particularly in the triple-negative subtype.
  • mtSrc promotes aggressiveness through phosphorylation of the mitochondrial single-stranded DNA-binding protein, leading to reduced mtDNA levels and mitochondrial dysfunction.
  • The subcellular localization of Src kinase, specifically within mitochondria, is a crucial factor in breast cancer progression and warrants consideration for therapeutic development.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.5K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.4K